O f the recognized subtypes of ischemic stroke, cortical infarction is the most common and is usually caused by atherothrombosis or thromboembolism, due chiefly to large-vessel and cardiac disease.1'2 In contrast, lacunar infarction, which accounts for approximately 15% of ischemic strokes, is due to occlusion of single, deep penetrating branches of the large cerebral arteries and is widely postulated to be caused by either lipohyalinosis or microatheroma. [2] [3] [4] However, the etiology of lacunar infarction remains controversial, and occasionally either small emboli, dissection of a small artery, or hemodynamic factors have been implicated. 4, 5 In adults, an estimated 1% to 4% of cases of ischemic stroke are due to primary hematologic disorders.6 These include the antiphospholipid antibody syndrome, hereditary deficiencies of coagulation inhibitors, abnormalities of fibrinolysis (plasminogen deficiency, abnormalities of tissue plasminogen activation, dysfibrinogenemia), thrombocytosis and qualitative platelet abnormalities, and erythrocyte disorders including polycythemia and paroxysmal nocturnal hemoglobinurea.6-10 Although these primary hematologic disorders are uncommon causes of ischemic stroke, other hemostatic derangements, which have often been assumed to occur as secondary phenomena, have been more frequently identified.1 -21 These abnormalities include enhanced fibrin formation (enhanced thrombin activity), abnormal fibrinolysis, and disturbed platelet function."1,2 Although these abnormalities could also be relevant to the etiology of ischemic stroke, enhanced thrombin activity also occurs in cerebral hemorrhage,1" suggesting that the enhancement may be caused by the nonspecific release of procoagulants from damaged cerebral tissue. Whatever its cause, enhanced thrombin activity may influence the progression of ischemic stroke by inducing the propagation of thrombus at the site of vascular occlusion. Moreover, the magnitude of the hemostatic abnormalities identified after a stroke may reflect the extent of tissue damage and likely prognosis. '1 It is uncertain whether the same spectra of hemostatic derangements occur in all types of ischemic stroke and, specifically, in both cortical and lacunar infarction. Previous studies suggest that these derangements may be confined to cortical infarction, '3-"7although 
Subjects and Methods
Nineteen consenting, nonconsecutive patients with acute cerebral infarction admitted to the Royal Melbourne Hospital were studied during 1988 to 1990. Patients with transient ischemic attacks were excluded from the study.
A detailed history, including time of stroke onset, prior history of smoking, hypertension, diabetes, myocardial infarction, malignancy, and surgery, was obtained (Tables 1 and 2 ). Preexisting therapy with either antiplatelet agents or warfarin was recorded. A full neurological examination was performed. Cerebral computed tomography (CT) was performed in all patients and was reported by a neuroradiologist. Cerebral digital subtraction angiography, carotid Doppler ultrasonography, and echocardiography were performed when clinically appropriate.
Strokes were classified according to accepted clinical and radiological criteria, as assessed by two neurologists and a neuroradiologist, as either lacunar or cortical cerebral infarcts.4 A diagnosis of lacunar infarction was made if the clinical deficit consisted of pure motor hemiplegia, pure sensory stroke, motor-sensory stroke, ataxic hemiparesis, or the dysarthria-clumsy hand syndrome, in the absence of visual field defects or abnormal cortical signs (see below) and with cerebral CT either normal or compatible with a small (less than 15 mm) deep infarct. A diagnosis of cortical cerebral infarction was made if there were cortical signs such as either apraxia, aphasia, cortical sensory function abnormalities, or neglect and if cerebral CT was either normal or showed features of acute cortical infarction. Patients who had intracranial hemorrhage were excluded from the study. In addition, patients with a history of either myocardial infarction, surgery in the 6 months before the stroke, or malignancy were excluded. The clinical features of patients with either infarct type are compared in Tables 1 and 2 ; other clinical differences between the two groups (for example, differences in blood pressure at presentation) were not observed. The patients studied represented a random sample of the 45 patients with lacunar infarcts and 240 patients with cortical infarcts who were admitted to the Royal Mel- exception of the FpA level, for which literature reference values were used29 and values from age-matched control subjects were obtained. Differences in hemostatic parameters were assessed using the Wilcoxon rank-sum test. Two-sided probability values are quoted.
Results
There were 10 patients with cortical cerebral infarction: 4 men and 6 women, with a mean age of 64.7 years (range, 15 to 90 years) ( Table 1) . One patient had a prior stroke. Clinical neurological deficits indicated cortical cerebral infarction in all of these patients. In the 5 patients with abnormal CT scans, the sites of the acute infarcts identified were consistent with the clinical deficit. In the 5 patients with normal CT scans, the procedure was performed within 24 hours of admission and was not repeated.
Cardiogenic cerebral embolism was diagnosed in 3 patients, all of whom had atrial fibrillation and mitral valve disease. Two of these patients received heparin initially and later warfarin. Three patients, on the basis of either digital subtraction angiography or carotid Doppler ultrasonography, were diagnosed as having cerebral infarction due to large-vessel atherosclerotic disease. They were all treated with aspirin. One of these patients also had a carotid endarterectomy. For 3 patients, the cause of cerebral infarction remained undetermined.
A diagnosis of lacunar infarction was made in 9 patients ( were reassessed for 3 of these 7 patients, and the levels were still elevated (mean±SD, 17 .2+12.9 ng/L). The initial FpA levels were similar in both infarct types (P=.86) and were significantly different from the published reference range (0.5 to 2.5 ng/L; n-25; P<.05). 9 It remained theoretically possible, however, that FpA levels were also elevated in age-matched control subjects in comparison to the literature reference range. To address this possibility, we analyzed FpA levels in 9 age-matched control subjects and found the mean±+ SD value to be 2.9±2.1 ng/L; 4 patients with lacunar infarcts and 6 with cortical infarcts had elevated FpA values outside this range. The differences between the mean FpA level for the control group and the lacunar and cortical infarct groups also approached statistical significance (P= .09).
The ELT (after occlusion) was used as a marker of impairment of fibrinolysis. On initial testing, 6 of 9 patients with lacunar infarction and 2 of 10 patients with cortical infarction had increased ELT. The mean values for the two cohorts were not significantly different (lacunar infarct group, 138.3+84 minutes; cortical infarct group, 84±60 minutes; PF.12). Of the 4 patients with abnormal fibrinolysis on initial testing who were reevaluated, 2 had repeat levels within the normal range 1 week after infarction and 1 had a normal level by 6 weeks after infarction.
Lupus anticoagulants were detected in 3 patients with lacunar infarcts and in 1 patient with a cortical infarct. Three patients with lacunar infarcts and 3 patients with cortical infarcts had decreased antithrombin III function. One patient with a lacunar infarct, who was not given warfarin, had a low protein C level, and plasminogen deficiency was detected in 1 patient. Discussion A number of previously reported studies have documented aberrations of hemostatic parameters in acute stroke. Shah et a113 documented raised levels of the platelet release proteins platelet factor 4 and ,B-thromboglobulin in patients with cortical infarction. Feinberg et al '4 reported elevated concentrations of FpA and patient presented with acute hemichorea, and cerebral cross-linked D-dimer in the first month after cortical infarction, and Fisher and Francis15 reported acutely elevated FpA and D-dimer levels in some patients. These studies did not, however, report hemostatic abnormalities in patients with lacunar infarcts. Recently, Takano et al16 found that a majority of patients with either atherothrombotic or lacunar stroke exhibited plasma hypercoagulability, which was partially related to an increase in factor VII activity. However, in a subsequent study,17 it was found that thrombotic and fibrinolytic activities in patients with lacunar infarction did not differ significantly from those of control patients in the first 30 days after cerebral infarction. Our data confirm that abnormalities of hemostatic function occur in cortical stroke but also suggest that enhanced thrombin activity may occur in lacunar infarction. We have identified elevated levels of FpA in patients with both cortical and lacunar infarction, and the results suggest that the activation of thrombin activity in lacunar infarction is at least as great as in cortical infarction. The reason why our study detected enhanced thrombin activity in patients with lacunar infarction, but previous studies have not, is not immediately apparent. It is possible that average infarct size differed between the studies, but previous reports have suggested that, at least for cortical infarction, there is no relation between stroke volume and FpA levels.14 The extent of the clinical neurological deficit and the stroke risk factor profile were not detailed in previous studies, but these factors are unlikely to explain the recorded differences. It has, however, been hypothesized that the pathogenesis of lacunar infarcts might reflect heterogeneous mechanisms,31 and this could potentially explain the variable results reported in these studies. For example, it could be that some lacunar infarcts arise secondarily to small emboli, and secondary thrombus could form around the occlusion site. Further, if hemodynamic factors are implicated, thrombus formation may represent the initial occlusive event. Alternatively, the release of thromboplastin from damaged parenchymal tissue may lead to enhanced thrombin activity if infarct size were to reach a critical volume. This is not to say that enhanced thrombotic activity is a phenomenon unique to ischemic stroke, as alterations in FpA levels32 have also been noted in post-acute myocardial infarction populations. Further, it is theoretically possible that some of the observed hemostatic abnormalities found in our study could However, these analyses were performed on a subset of those patients studied, and definitive conclusions with regard to this point await further, more extensive study. The detection of the lupus anticoagulant and of protein C deficiency in some of the patients with lacunar infarction raises the possibility of primary hematologic abnormalities in these patients. However, given the small numbers of patients involved, it remains uncertain as to whether these abnormalities are positively associated with lacunar infarction.
These findings are of potential therapeutic significance. The role of thrombolytic therapy, aimed at inducing the reperfusion of acute infarcts, is currently under intensive study.34-36 The appropriate deployment of this pharmacologic intervention in stroke requires an understanding of the pathogenesis, the etiology, and the abnormalities of hemostasis that occur in the various subtypes of ischemic stroke. Our results indicate that hemostatic abnormalities may occur not only in cortical infarction but also in lacunar infarction. Thus, we recommend further study of hemostatic parameters in patients with lacunar infarction; to do so appropriately, it will be necessary to assess large numbers of patients and to compare the values obtained with appropriate control groups. These groups should include age-, sex-, and also risk factor-matched control subjects in addition to patients with systemic ischemic disease (eg, myocardial infarction or peripheral vascular disease) to further delineate how and when abnormalities of hemostasis are generated. If the findings of the current study are confirmed, they may indicate that enhanced thrombin activity is implicated in the pathogenesis, if not the underlying etiology, of lacunar infarction and hence may be an important determinant in the selection of patients for thrombolytic therapy.
